Iris tumors are visible. Patients see them in the mirror and eye care specialists view them through the clear cornea. We use specialized ultrasound (UBM) and anterior segment OCT tests to reveal the contents, distribution, and size of these tumors. Most are benign and thus can be observed for growth prior to intervention. Others are either clinically diagnosed and treated or undergo biopsy. We review the differences between biopsy methods. In this Podcast, we will explore iris tumors, their diagnosis, and treatment.

Paul T. Finger, MD, FACS
The New York Eye Cancer Center
115 East 61st Street
New York City, New York, USA
10065

E-mail: [email protected]

Telephone: (011) 212 832 8170